
No transactions found.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenue | $36.9M-0.1% | $37.0M+5.8% | $34.9M-1.4% | $35.4M+17.6% | $30.1M |
| Total cost of revenue | $10.7M-6.9% | $11.5M-8.7% | $12.6M+12.4% | $11.2M+16.3% | $9.6M |
| Gross profit | $26.2M+2.9% | $25.5M+14.0% | $22.4M-7.8% | $24.3M+18.2% | $20.5M |
| Sales and marketing | $121.2M+8.2% | $112.0M+4.6% | $107.1M+0.7% | $106.4M+22.6% | $86.8M |
| Research and development | $8.5M-4.0% | $8.8M+12.9% | $7.8M+10.4% | $7.1M+25.3% | $5.7M |
| Reimbursement, general and administrative | $88.7M+24.7% | $71.1M+14.6% | $62.1M+2.1% | $60.8M+7.0% | $56.8M |
| Intangible asset amortization and earn-out | $2.4M-3.4% | $2.5M+3230.3% | $76K-99.5% | $14.4M+1852.9% | $739K |
| Total operating expenses | $220.9M+13.6% | $194.5M+9.8% | $177.1M-6.2% | $188.7M+25.8% | $150.0M |
| Income from operations | $29.3M+32.0% | $22.2M+22.9% | $18.0M | — | — |
| Interest income | $3.1M-8.5% | $3.4M+80.6% | $1.9M | — | — |
| Interest expense | -$1.0M+50.2% | -$2.1M+49.7% | -$4.1M-48.7% | -$2.8M | — |
| Other income | $1K-88.9% | $9K+350.0% | $2K-84.6% | $13K | — |
| Income before income taxes | $31.3M+33.4% | $23.5M+48.9% | $15.8M | — | — |
| Income tax expense (benefit) | $12.3M+87.7% | $6.5M+151.2% | -$12.7M-632.6% | $2.4M | — |
| Net income | $19.1M+12.5% | $17.0M-40.5% | $28.5M | — | — |
| Basic (in dollars per share) | $830+16.9% | $710-42.7% | $1K | — | -$600 |
| Diluted (in dollars per share) | $820+17.1% | $700-43.1% | $1K | — | -$600 |
| Basic (in shares) | $22.87B-4.2% | $23.88B+4.2% | $22.93B | — | $19.72B |
| Diluted (in shares) | $23.30B-3.5% | $24.14B+4.2% | $23.18B | — | $19.72B |
| Sales revenue | |||||
| Total revenue | $36.9M-0.1% | $37.0M+5.8% | $34.9M-1.4% | $35.4M+17.6% | $30.1M |
| Total cost of revenue | $10.7M-6.9% | $11.5M-8.7% | $12.6M+12.4% | $11.2M+16.3% | $9.6M |
| Gross profit | $26.2M+2.9% | $25.5M+14.0% | $22.4M-7.8% | $24.3M+18.2% | $20.5M |
| Rental revenue | |||||
| Total revenue | $36.9M-0.1% | $37.0M+5.8% | $34.9M-1.4% | $35.4M+17.6% | $30.1M |
| Total cost of revenue | $10.7M-6.9% | $11.5M-8.7% | $12.6M+12.4% | $11.2M+16.3% | $9.6M |
| Gross profit | $26.2M+2.9% | $25.5M+14.0% | $22.4M-7.8% | $24.3M+18.2% | $20.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
DexCom (DXCM) Q1 Earnings and Revenues Top Estimates
Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
How The Story Is Shifting For Tactile Systems Technology (TCMD) After Q4 And 2026 Guidance